Functional homologous recombination assay on FFPE specimens of advanced high-grade serous ovarian cancer predicts clinical outcomes
View ORCID ProfileSanna Pikkusaari, Manuela Tumiati, Anni Virtanen, Jaana Oikkonen, Yilin Li, Fernando Perez-Villatoro, Taru Muranen, Matilda Salko, Kaisa Huhtinen, Anna Kanerva, Heidi Koskela, Johanna Tapper, Riitta Koivisto-Korander, Titta Joutsiniemi, Ulla-Maija Haltia, Heini Lassus, Sampsa Hautaniemi, Anniina Färkkilä, Johanna Hynninen, Sakari Hietanen, Olli Carpén, View ORCID ProfileLiisa Kauppi
doi: https://doi.org/10.1101/2022.10.01.22280598
Sanna Pikkusaari
1Research Program in Systems Oncology, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland
Manuela Tumiati
1Research Program in Systems Oncology, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland
Anni Virtanen
2Department of Pathology, University of Helsinki and HUS Diagnostic Center, Helsinki University Hospital, Helsinki, Finland
Jaana Oikkonen
1Research Program in Systems Oncology, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland
Yilin Li
1Research Program in Systems Oncology, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland
Fernando Perez-Villatoro
1Research Program in Systems Oncology, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland
Taru Muranen
1Research Program in Systems Oncology, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland
Matilda Salko
1Research Program in Systems Oncology, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland
Kaisa Huhtinen
1Research Program in Systems Oncology, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland
Anna Kanerva
3Department of Obstetrics and Gynecology, Helsinki University Hospital, Helsinki, Finland
Heidi Koskela
4Department of Obstetrics and Gynecology, Turku University Hospital, Turku, Finland
Johanna Tapper
3Department of Obstetrics and Gynecology, Helsinki University Hospital, Helsinki, Finland
Riitta Koivisto-Korander
3Department of Obstetrics and Gynecology, Helsinki University Hospital, Helsinki, Finland
Titta Joutsiniemi
4Department of Obstetrics and Gynecology, Turku University Hospital, Turku, Finland
Ulla-Maija Haltia
3Department of Obstetrics and Gynecology, Helsinki University Hospital, Helsinki, Finland
Heini Lassus
3Department of Obstetrics and Gynecology, Helsinki University Hospital, Helsinki, Finland
Sampsa Hautaniemi
1Research Program in Systems Oncology, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland
Anniina Färkkilä
1Research Program in Systems Oncology, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland
5iCAN digital precision cancer medicine flagship, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
Johanna Hynninen
4Department of Obstetrics and Gynecology, Turku University Hospital, Turku, Finland
Sakari Hietanen
4Department of Obstetrics and Gynecology, Turku University Hospital, Turku, Finland
Olli Carpén
1Research Program in Systems Oncology, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland
2Department of Pathology, University of Helsinki and HUS Diagnostic Center, Helsinki University Hospital, Helsinki, Finland
Liisa Kauppi
1Research Program in Systems Oncology, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland
5iCAN digital precision cancer medicine flagship, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
Posted October 03, 2022.
Functional homologous recombination assay on FFPE specimens of advanced high-grade serous ovarian cancer predicts clinical outcomes
Sanna Pikkusaari, Manuela Tumiati, Anni Virtanen, Jaana Oikkonen, Yilin Li, Fernando Perez-Villatoro, Taru Muranen, Matilda Salko, Kaisa Huhtinen, Anna Kanerva, Heidi Koskela, Johanna Tapper, Riitta Koivisto-Korander, Titta Joutsiniemi, Ulla-Maija Haltia, Heini Lassus, Sampsa Hautaniemi, Anniina Färkkilä, Johanna Hynninen, Sakari Hietanen, Olli Carpén, Liisa Kauppi
medRxiv 2022.10.01.22280598; doi: https://doi.org/10.1101/2022.10.01.22280598
Functional homologous recombination assay on FFPE specimens of advanced high-grade serous ovarian cancer predicts clinical outcomes
Sanna Pikkusaari, Manuela Tumiati, Anni Virtanen, Jaana Oikkonen, Yilin Li, Fernando Perez-Villatoro, Taru Muranen, Matilda Salko, Kaisa Huhtinen, Anna Kanerva, Heidi Koskela, Johanna Tapper, Riitta Koivisto-Korander, Titta Joutsiniemi, Ulla-Maija Haltia, Heini Lassus, Sampsa Hautaniemi, Anniina Färkkilä, Johanna Hynninen, Sakari Hietanen, Olli Carpén, Liisa Kauppi
medRxiv 2022.10.01.22280598; doi: https://doi.org/10.1101/2022.10.01.22280598
Subject Area
Subject Areas
- Addiction Medicine (403)
- Allergy and Immunology (712)
- Anesthesia (206)
- Cardiovascular Medicine (2966)
- Dermatology (252)
- Emergency Medicine (445)
- Epidemiology (12800)
- Forensic Medicine (12)
- Gastroenterology (830)
- Genetic and Genomic Medicine (4617)
- Geriatric Medicine (423)
- Health Economics (732)
- Health Informatics (2940)
- Health Policy (1072)
- Hematology (393)
- HIV/AIDS (931)
- Medical Education (430)
- Medical Ethics (116)
- Nephrology (475)
- Neurology (4401)
- Nursing (238)
- Nutrition (648)
- Oncology (2291)
- Ophthalmology (651)
- Orthopedics (260)
- Otolaryngology (327)
- Pain Medicine (280)
- Palliative Medicine (84)
- Pathology (502)
- Pediatrics (1199)
- Primary Care Research (502)
- Public and Global Health (6992)
- Radiology and Imaging (1542)
- Respiratory Medicine (920)
- Rheumatology (444)
- Sports Medicine (386)
- Surgery (491)
- Toxicology (60)
- Transplantation (212)
- Urology (182)